Literature DB >> 29278516

Serum fetuin-A levels are associated with serum triglycerides before and 6 months after bariatric surgery.

Christos G Verras1, Georgios A Christou2, Yannis V Simos2, George D Ayiomamitis3, Andreas J Melidonis1, Dimitrios N Kiortsis4.   

Abstract

OBJECTIVE: The elucidation of the changes of fetuin-A in the context of bariatric surgery.
DESIGN: Twenty obese patients (8 males, 12 females; body mass index = 42.5±3.4 kg/m2) were studied at baseline and 6 months after bariatric surgery.
RESULTS: Serum fetuin-A levels did not differ with regard to the presence of each individual component of the Metabolic Syndrome (MetS) at baseline, except for hypertriglyceridaemia [increased serum fetuin-A levels (p=0.011)]. Circulating fetuin-A was positively correlated with serum triglycerides (TG) (r=0.461, p=0.047) and negatively correlated with serum globulins (r=-0.477, p=0.033) and C-reactive protein (CRP) (r=-0.604, p=0.010), while it independently predicted TG at baseline. Circulating fetuin-A did not change during the 6 months either in the whole population or in the subgroups of patients who were positive for each individual component of MetS at baseline and negative for this component at 6 months of follow-up, except for hypertriglyceridaemia [reduction of serum fetuin-A levels (p=0.046)]. The subgroup of patients with a decrease in circulating fetuin-A during the 6 months was characterized by a smaller reduction of serum globulins (p=0.003) and CRP (p=0.049). The change in serum fetuin-A levels over the 6 months was positively correlated with the change in TG (r=0.592, p=0.006) and negatively correlated with the change in serum globulins (r=-0.523, p=0.018) and CRP (r=-.494, p=0.037).
CONCLUSIONS: Circulating fetuin-A predicted serum triglycerides before as well as 6 months after bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29278516     DOI: 10.14310/horm.2002.1739

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  5 in total

1.  Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.

Authors:  Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Moor; Philipp Madörin; Andreas Schötzau; Diana Nabers; Stefan Borgwardt; Christoph Beglinger; Oliver Bieri; Bettina K Wölnerhanssen
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

2.  Hepatokines Fetuin-A and Fetuin-B status in obese Saudi patient with diabetes mellitus type 2.

Authors:  Ola Almarashda; Saba Abdi; Sobhy Yakout; Malak Nawaz Khan Khattak; Nasser M Al-Daghri
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Jihua Chen; Miyang Luo; Jiayou Luo
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

4.  Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?

Authors:  Hsien-Hao Huang; Chun Yeh; Jung-Chien Chen; Tzong-Hsi Lee; Shu-Chun Chen; Wei-Jei Lee; Chih-Yen Chen
Journal:  PeerJ       Date:  2018-06-12       Impact factor: 2.984

Review 5.  Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review.

Authors:  Lynda Bourebaba; Krzysztof Marycz
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.